Tango Therapeutics (TNGX) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to $0.13.
- Tango Therapeutics' EPS (Weighted Average and Diluted) rose 148.15% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.92, marking a year-over-year increase of 20.69%. This contributed to the annual value of -$1.19 for FY2024, which is 10.19% down from last year.
- Tango Therapeutics' EPS (Weighted Average and Diluted) amounted to $0.13 in Q3 2025, which was up 137.14% from -$0.35 recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' EPS (Weighted Average and Diluted) peaked at $0.13 during Q3 2025, and registered a low of -$0.36 during Q1 2025.
- For the 3-year period, Tango Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.26, with its median value being -$0.30 (2023).
- Within the past 5 years, the most significant YoY rise in Tango Therapeutics' EPS (Weighted Average and Diluted) was 148.15% (2025), while the steepest drop was 45.83% (2025).
- Tango Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.26 in 2021, then dropped by 26.92% to -$0.33 in 2022, then rose by 9.09% to -$0.30 in 2023, then decreased by 13.33% to -$0.34 in 2024, then surged by 148.15% to $0.13 in 2025.
- Its last three reported values are $0.13 in Q3 2025, -$0.35 for Q2 2025, and -$0.36 during Q1 2025.